Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Rocket Pharmaceuticals (RCKT) over the last 4 years, with Q2 2025 value amounting to -$29000.0.

  • Rocket Pharmaceuticals' Other Operating Expenses changed N/A to -$29000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$29000.0, marking a year-over-year change of. This contributed to the annual value of -$78.2 million for FY2018, which is 11881.43% down from last year.
  • Rocket Pharmaceuticals' Other Operating Expenses amounted to -$29000.0 in Q2 2025.
  • In the past 5 years, Rocket Pharmaceuticals' Other Operating Expenses registered a high of -$29000.0 during Q2 2025, and its lowest value of -$29000.0 during Q2 2025.